Fundraising Fox
Qu Biologics
Burnaby · 2 known investors
Find your way into Qu Biologics
Sign up to see every warm intro you have to Qu Biologics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Qu Biologics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Qu Biologics develops treatments aimed at cancer, chronic inflammatory diseases, and metabolic diseases by restoring normal immune function. It operates in the biotech and immunotherapy space.
Founders & leadership
HG
Hal GunnCEOHal Gunn is a physician who previously co-founded and served as CEO of InspireHealth, a supportive cancer care organization in British Columbia, and now leads Qu Biologics as founder and CEO, developing immunotherapy treatments for cancer and chronic inflammatory diseases.
SS
Simon SutcliffeChief Medical Officer
AR
Alun ReesNamed on SEC filing
RE
Robert E. PelzerNamed on SEC filing
ML
Michael LeschukNamed on SEC filing
GV
Gillian VandermeirschNamed on SEC filing
JP
Jim PankovichNamed on SEC filing
JL
Julia LevyNamed on SEC filing
Investors · 2
Funding
SEC filings, press & company announcements$12M disclosed across 2 rounds · 2018–2022
- $12MraisedMar 2022 · 2 sourcesSource ↗
▶$48.8KraisedJun 2018 · 1 investors · BiotechnologyRule 506(b)
▶$48.8KraisedJun 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Simon SutcliffeExecutive Officer, Director
- Alun ReesExecutive Officer
- Robert E. PelzerDirector
- Michael LeschukDirector
- Harold David GunnExecutive Officer, Director
- Gillian VandermeirschExecutive Officer
- Jim PankovichExecutive Officer
- Julia LevyDirector
- Offering amount
- $77.6K
- Amount sold
- $48.8K
- First sale
- May 2018
- Incorporated
- Corporation, British Columbia, Canada
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Q32 BioQ32 Bio is a biotechnology company developing therapies for autoimmune and inflammatory diseases, with a scientific focus on the complement system and immune regulation in conditions such as inflammation, autoimmunity and fibrosis. The company was formed through a merger with Homology Medicines in 2024 and is led by a team with immunology and biopharmaceutical drug development experience.
Q Bio, Inc.Q.bio provides quantitative biology assessments and longitudinal health monitoring for preventive care, offering comprehensive measurable exams at the scale of premium care providers.
Companies working in the same space as Qu Biologics.
In the news
Frequently asked questions
- What does Qu Biologics do?
- Qu Biologics develops treatments aimed at cancer, chronic inflammatory diseases, and metabolic diseases by restoring normal immune function. It operates in the biotech and immunotherapy space.
- Who founded Qu Biologics?
- Qu Biologics was founded by Hal Gunn.
- Who are Qu Biologics's investors?
- Qu Biologics's investors include Curitas Ventures, Harmonix Fund.
- How much funding has Qu Biologics raised?
- Qu Biologics has disclosed $12M raised across 2 rounds.
- Where is Qu Biologics headquartered?
- Qu Biologics is headquartered in Burnaby.